ICAP recently celebrated major milestones in its support of HIV prevention, care and treatment programs around the world. Through ICAP support, over 1 million people have received access to live-saving treatment and grown to support over 3,380 sites. Key to reaching global HIV treatment goals is the need for an expanded clinical role for nurses and midwives, including initiating and managing patients on antiretroviral treatment (ART), in countries that face a shortage of health care workers. New ambitious treatment goals for adults and children as well as for the scale-up of the Option B+ for PMTCT compel the need to continue pre-service and in-service education, training and mentorship for the nursing workforce.
U.S. government programs have recently received attention in mainstream media for efforts to address healthcare worker shortages in sub-Saharan Africa by strengthening medical education. ICAP is pleased to be implementing similar programs that aim specifically to increase capacity for nursing and midwifery institutions in Democratic Republic of Congo, Ethiopia, Lesotho, Malawi, and Zambia.
ICAP’s regional nurse advisor, Dr. Lyn Middleton and Dr. Wafaa El-Sadr, ICAP director, recently co-authored an article with funding partner HRSA on the Nursing Education Partnership Initiative in this month’s issue of Academic Medicine.
Following the International AIDS Conference in Melbourne in July, ICAP sponsored a symposium in Yangon, Myanmar to share updates from the conference and discuss the most recent advances in the global effort against HIV.
With PEPFAR support through the US Centers for Disease Control (CDC), ICAP has launched a new data-driven website dedicated to the Swaziland HIV Incidence Measurement Survey (SHIMS). Initiated by the Government of the Kingdom of Swaziland’s Ministry of Health, SHIMS was supported by PEPFAR and implemented by ICAP in 2010-2011. The first nationally representative, population-based survey of its kind, SHIMS measured HIV incidence through direct observations of new infections.
Today we recognize an important milestone. Over 1 million persons living with HIV have initiated life-saving antiretroviral treatment (ART) through ICAP-supported programs. After a decade of work in partnership with governmental, non-governmental and community-based organizations around the world and with support from PEPFAR and other funders, this milestone is an important step on the path to confronting the global HIV epidemic.
Since beginning its first multi-country HIV treatment initiative in 2003, ICAP has grown to support over 3,380 sites across sub-Saharan Africa, Central and Southern Asia. In the past year alone, ICAP expanded support to 320 additional health facilities with the most substantial increases in Ethiopia, Kenya, and Cote d’Ivoire.
The history of public health is full of aspirational campaigns. But do statements like “the end of AIDS” help or hurt? Do they motivate action, or do they risk incredulity, leading to inaction?
In a new editorial published in Science, End of AIDS: Hype versus Hope, ICAP’s Wafaa El-Sadr and Katherine Harripersaud, with co-author Ron Bayer, consider these questions.